Moolec Science Secures Nasdaq Exception, Boosts Equity by Over $100M via Subsidiary Derecognition
MLEC has more than doubled off its 52-week low of $3.077 on elevated volume (19× avg).
Summary
Moolec Science SA has received an exception from Nasdaq until June 29, 2026, to regain compliance with listing requirements, reporting an estimated increase of over $100 million in stockholders' equity due to the derecognition of bankrupt subsidiaries.
Key Events · Corporate Governance and Compliance · MLEC
-
Nasdaq Compliance Exception
Moolec Science SA received an exception from the Nasdaq Hearings Panel until June 29, 2026, to regain compliance with the stockholders' equity requirement, mitigating immediate delisting concerns.
-
Significant Equity Increase
The company reported an estimated increase of approximately $100.8 million in stockholders' equity, which it believes brings it into compliance with Nasdaq's listing rules.
-
Derecognition of Bankrupt Subsidiaries
This equity increase stems from accounting gains recognized due to the loss of control over subsidiaries Bioceres S.A., Bioceres LLC, and Theo I SCSp, following their bankruptcy proceedings in December 2025.
Analysis · MLEC · Manufacturing
The Nasdaq Hearings Panel granted Moolec Science an exception, extending its deadline to meet the stockholders' equity requirement until June 29, 2026. This temporary relief from potential delisting is a critical development for the company. Moolec believes it has already regained compliance, attributing an estimated $100.8 million increase in stockholders' equity to accounting gains from the derecognition of subsidiaries (Bioceres S.A., Bioceres LLC, and Theo I SCSp) following their respective bankruptcy proceedings. While the underlying bankruptcies of subsidiaries are negative operational events, the resulting accounting gains significantly improve Moolec's balance sheet and address a key listing compliance issue, providing a positive signal for the company's immediate future on Nasdaq.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MLEC was trading at $6.60 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $3.08 to $157.05. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.